Summary & Overview
HCPCS Level II J1320: Injection, Amitriptyline HCl up to 20 mg
HCPCS Level II code J1320 denotes an injection of amitriptyline hydrochloride up to 20 mg. Nationally, this code captures billing for parenteral administration of a tricyclic antidepressant formulation used in specific clinical circumstances, often when oral therapy is not feasible. Accurate coding of J1320 affects billing clarity for outpatient clinics, infusion centers, and physician offices that administer medication injections.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a synthesis of relevance for these payers, including coverage considerations and common billing practices reported for medication injections. The publication provides clinical context for when an injectable amitriptyline product may be used, expected sites of service, and how J1320 is positioned among medication injection codes.
This summary prepares clinicians, billing staff, and policy analysts to understand where J1320 fits in service lines and payer interactions. The full content includes benchmarks where available, documentation expectations, and a concise policy-oriented discussion to support accurate claim submission and programmatic tracking.
Billing Code Overview
HCPCS Level II code J1320 represents an injection of amitriptyline hydrochloride, billed for doses up to 20 mg per unit. The service is a medication injection typically administered for off-label indications where parenteral amitriptyline is used.
Service Type: Injection / Medication Administration
Typical Site of Service: Clinic, outpatient infusion center, or physician office
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 55-year-old patient with chronic neuropathic pain refractory to oral therapies presents to an outpatient pain management clinic for targeted intramuscular/infiltration therapy. The clinician orders an injectable amitriptyline formulation J1320 (Injection, amitriptyline HCl, up to 20 mg) to be administered as a single in-office dose into a localized region (for example, paraspinal or peripheral nerve trigger point) during a scheduled procedure visit. The workflow includes pre-procedure consent and pain assessment, medication preparation by nursing in the clinic medication room, verification of correct dose and patient identity, administration by a qualified provider (physician or advanced practice clinician) with appropriate monitoring for adverse effects (vital signs and observation for anticholinergic or cardiac effects), documentation of medication lot and amount, and post-procedure instructions. Billing captures the J1320 HCPCS Level II code for the drug supplied, and may include an appropriate evaluation and management or procedure CPT code if a separate billable service is provided during the same encounter. Typical sites of service include an outpatient pain clinic, ambulatory surgical center, or office-based procedure suite. Common patient scenarios include localized neuropathic pain, myofascial pain referral, or refractory neuralgias where local injectable tricyclic therapy is trialed after systemic routes have been insufficient or intolerable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|